Prot #7465-CL-0108: A Multicenter, Open-label, Expanded Access Treatment Protocol of Enfortumab Vedotin in Subjects with Locally Advanced or Metastatic Urothelial Carcinoma (EV-901)

Project: Research project

StatusActive
Effective start/end date12/17/1912/17/22

Funding

  • Parexel (Prot #7465-CL-0108)
  • Astellas Pharma Global Development, Inc. (Prot #7465-CL-0108)